Clinical trial
Lucentis for Treatment of Macular Edema
NCT00464581 · Retina Institute of Hawaii, Other · Completed
Key facts
| NCT number | NCT00464581 |
|---|---|
| Title | Lucentis for Treatment of Macular Edema |
| Official title | A Single-center Phase 2 Trial of Intravitreous Injections of Lucentis (Ranibizumab) in Subjects With Cystoid Macular Edema Secondary to Non-ischemic Retinopathy |
| Acronym | FVF4153s |
| Lead sponsor | Retina Institute of Hawaii, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Cystoid Macular Edema |
| Enrollment | 30 |
| Start date | May 1, 2007 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Apr 23, 2007 |
| Last update posted | May 28, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: